Loading
companiesCompany
Italfarmaco
Italfarmaco is a Italy-based pharmaceutical company running 2 late-stage cancer trials of givinostat and Givinostat in myeloproliferative neoplasms.
Overview
Italfarmaco, based in Milan, Italy, is a pharmaceutical company. Italfarmaco is a pharmaceutical group that researches, develops and manufactures medicines, with a particular focus on rare diseases. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials (1 in phase 3), testing givinostat and Givinostat in myeloproliferative neoplasms. The largest, NCT06093672 (Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera), plans to enrol 220 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.
Headquarters
Milan, IT
Scorecard
All companies#302of 1244 companies, score 14
- phase 3 +3
- modalities +2
- registry trials +9
0 approved, 1 in phase 3, 0 earlier, 0 targets, 19 registry studies. Formula on the scorecards page.
Type
Stage
Large private
Website
Founded
1938
Phase 3small molecule
Givinostat is an experimental small-molecule drug from Italfarmaco in phase 3 trials for myeloproliferative neoplasms, with its target not yet stated publicly.
Similar pages
cancers
drugs
Phase 3small molecule